Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

  Refine by:

Refine by:

Format

2 records – page 1 of 1.

CTC 2017 : compendium of therapeutic choices

https://bccalibrary.andornot.com/en/permalink/catalog120260
Adamko, Darryl J., Arnason, Terra, Bailey, Benoit. [Ottawa, ON]: Canadian Pharmacists Association , 2017. [8th ed].
Audience
Professional
Call Number
WB300 C737 2017
Availability
3 copies, 3 available
More Information
Alternate Title
Compendium of therapeutic choices
Therapeutic choices
Author
Adamko, Darryl J.
Arnason, Terra
Bailey, Benoit
Corporate Author
Canadian Pharmacists Association
Edition
[8th ed]
Place of Publication
[Ottawa, ON]
Publisher
Canadian Pharmacists Association
Publication Date
2017
Physical Description
xxvi, 1969 p. ; 24 cm.
Subjects
Drug Therapy
Pharmaceutical Preparations - administration & dosage
Disease - diagnosis
Medicine
Handbooks
Notes
Ch. 126 Chemotherapy-induced nausea and vomiting authored by Lynne Nakashima.
ISBN
9781894402989
ISSN
2368-0210
Language
English
Material Type
Book
Audience
Professional
Location
Vancouver Library REF
Abbotsford Library REF
Victoria Library REF
Call Number
WB300 C737 2017

Copies

c.1 BC Cancer Agency VAN Library REF Available
c.1 BC Cancer Agency ARHCC Library REF Available
c.1 BC Cancer Agency VIC Library REF Available
Show Less

RANK ligand : a key signal in cancer-induced bone disease and hormone ablative therapy-induced bone loss

https://bccalibrary.andornot.com/en/permalink/catalog19811
Amgen Inc. Thousand Oaks, Calif.: Amgen Inc. , 2009.
Audience
Professional
Call Number
WE258 R198 2009
Availability
1 copy, 1 available
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
More Information
Author
Amgen Inc.
Place of Publication
Thousand Oaks, Calif.
Publisher
Amgen Inc.
Publication Date
2009
Subjects
RANK Ligand - metabolism
Osteoblasts
Osteoclasts
Antibodies, Monoclonal - therapeutic use
Bone Neoplasms - secondary
Bone Resorption
Osteoporosis - therapy
Antineoplastic Agents, Hormonal - adverse effects
Abstract
Introduction
RANK ligand in bone biology
Bone metastases
Multiple myeloma
Skeletal-related events (SREs)
Hormone ablative therapy-induced bone loss
Language
English
Material Type
Video
DVD
Audience
Professional
Location
Abbotsford Library
Call Number
WE258 R198 2009

Copies

c.1 BC Cancer Agency ARHCC Library Available
Show Less